By Type
Aimed Alliance’s New Report on AFPs: Navigating Today’s Pharmacy Benefits Efficiently, Effectively, and Ethically
The rising cost of healthcare, and prescription drugs in particular, is a source of anxiety for employers with each new…
NEW White Paper on Alternative Funding Programs
In recent years, the adoption of alternative funding programs (AFPs) among self-funded employer-sponsored plans has risen rapidly. However, few employers…
Aimed Alliance Publishes Recommendations for State and Federal 340B Reform
Aimed Alliance has released new recommendations for reforming the federal 340B Drug Pricing Program and advancing state-based alternatives to strengthen…
Aimed Alliance Submits Comment on Senate Finance Drug Pricing RFI
On August 14, Aimed Alliance submitted a comment to the Senate Finance Committee’s Request for Information on Commonsense Policy Options…
Aimed Alliance & NORM Release 2026 Open Enrollment Brochures
The 2026 Open Enrollment period is fast approaching! The 2026 Open Enrollment period for Medicare Advantage plans is October 15,…
Aimed Alliance publica un nuevo recurso que explica las implicaciones de la revocación de la NBPP de 2021
A la luz de la reciente decisión del HIV + Hepatitis Policy Institute, et al. v. Health and Human Services…
Share Your Experience: Treatment Access & Your Mental Health Care
Alliance for Mental Health Care Access Survey The Alliance for Mental Health Care Access (AMHCA) is excited to share a…
New Aimed Alliance Infographic Identifies Best Practices for Migraine Management in the Workplace
A new Aimed Alliance infographic demonstrates ongoing challenges employees with migraine disease face in the workplace and best practices employers…
Aimed Alliance Receives Interim Response to FDA Citizen Petition
On August, 28, 2024, Aimed Alliance received an interim response from the Food and Drug Administration regarding its Citizen Petition…
Aimed Alliance to Speak at the Ohio Rare Disease Summit
Aimed Alliance’s Counsel, Ashira Vantrees, will be speaking to employers at the Ohio Rare Disease Summit on “Managing Prescription Drug…
